|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
HIV 1/2 Rapid Antibody Screen
Test CodeHIVRS2
Alias/See Also
SUDS, Rapid HIV, HIV Rapid Screening Test
Includes
HIV Rapid Screen, Comment
Preferred Specimen
4.0 mL whole blood (3.0 mL minimum)
Transport Container
EDTA (lavender/purple top)
Specimen Stability
Room temperature / Refrigerated (2-30C): 5 days, Frozen: not recommended
Methodology
Immunoassay
Limitations
The OraQuick HIV-1 and 2 assay is intended for use as a rapid SCREENING test for the presence of HIV-1 and 2 antibodies in whole blood/plasma.
Positive results using OraQuick method must be tested by Western Blot and Western Blot must be positive to confirm the presence of HIV antibody. Repeat testing in 3-6 months is recommended in positive screening tests that are negative by Western Blot. Negative screening tests indicate that no antibody to HIV-1 or 2 was detected. Patients exposed to high risk activity in the past three months may be falsely negative.
Positive results using OraQuick method must be tested by Western Blot and Western Blot must be positive to confirm the presence of HIV antibody. Repeat testing in 3-6 months is recommended in positive screening tests that are negative by Western Blot. Negative screening tests indicate that no antibody to HIV-1 or 2 was detected. Patients exposed to high risk activity in the past three months may be falsely negative.
Reference Range
Non-reactive
Clinical Significance
This is a qualitative immunoassay to detect antibodies to the Human Immunodeficiency virus types 1 and 2
